

HY-156034 · 50 mg
MedChemExpress · Cat: HY-156034
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/jt001.html
Description
JT001 NLRP3-IN-19 is a potent, specific and orally active inhibitor of NLRP3. JT001 can inhibit NLRP3 inflammasome assembly, resulting in the inhibition of cytokine release and the prevention of pyroptosis. JT001 can be used for the research of nonalcoholic steatohepatitis and liver fibrosis.







